Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
hsa-miR-34a-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factor
Not available
Downstream target
Not available
Differential expression in
recurrence vs. nonrecurrence
Not available
Cancer name
Non-Muscle-Invasive Bladder Cancer
Alias
Bladder Cancer
Cancer site
Bladder
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Up
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
63
Male patients
Not available
Female patients
Not available
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
MiR-34a-3p is an independent biomarker of NMIBC recurrence and a promising candidate for fur-ther independent validations as an additional factor to improve predictive value of European Organization for Research and Treatment of Cancer nomogram.
Tissue resource
primary non-muscle-invasive bladder cancer tissues
Experiment
qRT-PCR
Institute
Department of Urologic Oncology, Masaryk Memorial Cancer Institute
Country
Czech Republic
Continent
Europe
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.